Trademark: 85102816
Word
SALICINIUM
Status
Dead
Status Code
710
Status Date
Friday, November 16, 2018
Serial Number
85102816
Registration Number
4123876
Registration Date
Tuesday, April 10, 2012
Mark Type
4000
Filing Date
Monday, August 9, 2010
Published for Opposition
Tuesday, January 24, 2012
Cancellation Date
Friday, November 16, 2018

Trademark Owner History
COGNATE 3 LLC - Original Registrant

Classifications
5 Drug preparations, liquid drug formulations, prescription and non-prescription medications, namely, capsules, tablets, powders, and pharmaceutical preparations, injectable pharmaceuticals, topical formulations and patches, infusion pharmaceutical preparations, intravenous pharmaceutical formulations, and pharmaceutical solutions for medical and nutritional purposes and uses, namely, for treatment of immune disorders, immune deficiencies, cellular proliferative disorders, namely, cancer, bacterial, viral and fungal infections, physiological pH imbalances, digestive disorders, and nutritional and dietary deficiencies; Drugs and medications namely, anti-inflammatories, pharmaceutical preparations used in cancer therapeutics, antiseptics, antibiotics, antivirals, antifungal preparations, antimicrobial preservatives for cosmetics and pharmaceuticals, pharmaceutical preparations for the treatment of immune system related diseases and disorders, immune supplemental, nutritional supplements for stimulating the immunity system, pharmaceutical preparations for wound healing, nutritional supplements for balancing immune system-related factors, namely, blood sugar and pH levels, nutritional supplements for adjusting and balancing pH levels and other immune system-related factors, and dietary supplements and balancing drugs and medications, namely, medications incorporating active drugs and other therapeutic agents effective for alleviating immune disorders, immune deficiencies, cellular proliferative disorders, physiological pH imbalances, digestive disorders, and nutritional and dietary deficiencies, all for oral, topical, intravenous, injection and infusion therapy

Trademark Events
Nov 16, 2018
Cancelled Sec. 8 (6-Yr)
Apr 10, 2017
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Apr 10, 2012
Registered-Principal Register
Jan 24, 2012
Official Gazette Publication Confirmation E-Mailed
Jan 24, 2012
Published For Opposition
Jan 4, 2012
Notification Of Notice Of Publication E-Mailed
Dec 17, 2011
Law Office Publication Review Completed
Dec 12, 2011
Approved For Pub - Principal Register
Dec 12, 2011
Examiner's Amendment Entered
Dec 12, 2011
Notification Of Examiners Amendment E-Mailed
Dec 12, 2011
Examiners Amendment E-Mailed
Dec 12, 2011
Examiners Amendment -Written
Dec 10, 2011
Notification Of Final Refusal Emailed
Dec 10, 2011
Final Refusal E-Mailed
Dec 10, 2011
Final Refusal Written
Nov 19, 2011
Teas/Email Correspondence Entered
Nov 19, 2011
Correspondence Received In Law Office
Nov 14, 2011
Assigned To Lie
Oct 31, 2011
Teas Response To Office Action Received
Apr 29, 2011
Notification Of Non-Final Action E-Mailed
Apr 29, 2011
Non-Final Action E-Mailed
Apr 29, 2011
Non-Final Action Written
Sep 13, 2010
Notification Of Non-Final Action E-Mailed
Sep 13, 2010
Non-Final Action E-Mailed
Sep 13, 2010
Non-Final Action Written
Sep 13, 2010
Assigned To Examiner
Aug 12, 2010
New Application Office Supplied Data Entered In Tram
Aug 12, 2010
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24